Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Share-based Compensation (2021 - 2025)

Zymeworks' Share-based Compensation history spans 3 years, with the latest figure at $3.4 million for Q4 2023.

  • For Q4 2023, Share-based Compensation fell 25.08% year-over-year to $3.4 million; the TTM value through Dec 2023 reached $8.1 million, up 101.79%, while the annual FY2025 figure was $28.0 million, 57.57% up from the prior year.
  • Share-based Compensation for Q4 2023 was $3.4 million at Zymeworks, up from $2.0 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $4.8 million in Q3 2022 and bottomed at -$8.2 million in Q1 2022.
  • The 3-year median for Share-based Compensation is $2.3 million (2023), against an average of $1.2 million.
  • The largest annual shift saw Share-based Compensation surged 366.15% in 2022 before it crashed 87.32% in 2023.
  • A 3-year view of Share-based Compensation shows it stood at -$1.7 million in 2021, then skyrocketed by 366.15% to $4.5 million in 2022, then fell by 25.08% to $3.4 million in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Share-based Compensation are $3.4 million (Q4 2023), $2.0 million (Q3 2023), and $367000.0 (Q2 2023).